Encyclopedia
Monalizumab
Monoclonal antibody
Monalizumab, a humanized anti-NKG2A antibody(formerly IPH2201) is an investigational drug being studied for rheumatoid arthritis, gynecologic malignancies and other cancers.
01Mechanism of action
Monalizumab is a monoclonal antibody targeted at NKG2A. It is a checkpoint inhibitor.
Sources and credits
This article is adapted from the Wikipedia article “Monalizumab”, written by its contributors and licensed under CC BY-SA 4.0. Fathomly has changed the layout, removed citation markers, navigation and maintenance notices, and adjusted punctuation. This adapted version is shared under the same license. For references, see the original article.
Fathomly is not affiliated with or endorsed by the Wikimedia Foundation. Spotted a problem? Tell us.